These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


77 related items for PubMed ID: 5602113

  • 21. [Present state of heparin therapy].
    Blatrix C, Soulier JP, Vacheron A, Cornu P.
    Presse Med (1893); 1969 Mar 26; 77(15):553-6. PubMed ID: 5796027
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Heparin and protamine titration do not improve haemostasis in cardiac surgical patients.
    Shore-Lesserson L, Reich DL, DePerio M.
    Can J Anaesth; 1998 Jan 26; 45(1):10-8. PubMed ID: 9466020
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. A four-year experience with patient individualized heparin and protamine dosing using the Hemochron RxDx system.
    Bennett KM, Briggins D, Zucker M, LaDuca F.
    J Extra Corpor Technol; 2001 Feb 26; 33(1):19-22. PubMed ID: 11315128
    [Abstract] [Full Text] [Related]

  • 27. [An optimal coagulation method to determine anti-heparin compounds in biological specimens].
    Roszkowska-Jakimiec W.
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 2001 Feb 26; 31-32():143-51. PubMed ID: 3152143
    [No Abstract] [Full Text] [Related]

  • 28. Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery.
    Vonk AB, Veerhoek D, van den Brom CE, van Barneveld LJ, Boer C.
    J Cardiothorac Vasc Anesth; 2014 Apr 26; 28(2):235-41. PubMed ID: 24342152
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. A comparison of thromboelastography with heparinase or protamine sulfate added in vitro during heparinized cardiopulmonary bypass.
    Spiess BD, Wall MH, Gillies BS, Fitch JC, Soltow LO, Chandler WL.
    Thromb Haemost; 1997 Aug 26; 78(2):820-6. PubMed ID: 9268178
    [Abstract] [Full Text] [Related]

  • 35. [Effect of regulating blood clotting with heparin and its antagonists on mast cells].
    Efimov VS, Rozkin MIa, Poberiĭ IA, Lindner DP.
    Farmakol Toksikol; 1981 Aug 26; 44(1):80-5. PubMed ID: 7262304
    [Abstract] [Full Text] [Related]

  • 36. Myocardial effects of protamine.
    Avellanal M, Barrigón S.
    J Cardiothorac Vasc Anesth; 2007 Oct 26; 21(5):779. PubMed ID: 17905299
    [No Abstract] [Full Text] [Related]

  • 37. Safety issues in heparin and protamine administration for extracorporeal circulation.
    Jobes DR.
    J Cardiothorac Vasc Anesth; 1998 Apr 26; 12(2 Suppl 1):17-20. PubMed ID: 9583571
    [Abstract] [Full Text] [Related]

  • 38. Protamine dosage based on two titrations reduces blood loss after valve replacement surgery: a prospective, double-blinded, randomized study.
    Guo Y, Tang J, Du L, Liu J, Liu RC, Liu X, Guo Y.
    Can J Cardiol; 2012 Apr 26; 28(5):547-52. PubMed ID: 22633184
    [Abstract] [Full Text] [Related]

  • 39. Management of intentional overdose of low-molecular-weight heparin.
    Lu C, Crowther MA, Mithoowani S.
    CMAJ; 2022 Jan 31; 194(4):E122-E125. PubMed ID: 35101871
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 4.